These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2232714)

  • 1. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
    Sabatini M; Yates AJ; Garrett IR; Chavez J; Dunn JF; Bonewald L; Mundy GR
    Lab Invest; 1990 Nov; 63(5):676-82. PubMed ID: 2232714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
    Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
    Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR
    Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA; Yoneda T; Yates AJ; Mundy GR
    J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
    Yates AJ; Boyce BF; Favarato G; Aufdemorte TB; Marcelli C; Kester MB; Walker R; Langton BC; Bonewald LF; Mundy GR
    J Bone Miner Res; 1992 Jul; 7(7):847-53. PubMed ID: 1642153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
    Hirschel-Scholz S; Caverzasio J; Rizzoli R; Bonjour JP
    J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.
    Linkhart TA; Mohan S; Jennings JC; Baylink DJ
    Cancer Res; 1989 Jan; 49(2):271-8. PubMed ID: 2535957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice.
    Sato K; Satoh T; Shizume K; Yamakawa Y; Ono Y; Demura H; Akatsu T; Takahashi N; Suda T
    Cancer Res; 1992 Jan; 52(2):444-9. PubMed ID: 1728416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-related protein and transforming growth factor activities in an extract from a breast cancer associated with humoral hypercalcemia of malignancy.
    Nagata N; Yasutomo Y; Kugai N; Matsuura Y; Akatsu T; Sugiyama K; Kinoshita T; Takatani O; Mamiya Y; Yamaguchi K
    Jpn J Clin Oncol; 1989 Dec; 19(4):353-9. PubMed ID: 2558242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
    Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice.
    Johnson RA; Boyce BF; Mundy GR; Roodman GD
    Endocrinology; 1989 Mar; 124(3):1424-7. PubMed ID: 2917519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral hypercalcemia caused by a rat Leydig-cell tumor is associated with suppressed parathyroid hormone secretion and increased urinary cAMP excretion.
    Spiegel AM; Saxe AW; Deftos LJ; Brennan MF
    Horm Metab Res; 1983 Jun; 15(6):299-304. PubMed ID: 6307850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM; Morris CA; Mitnick MA; Insogna KL
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy.
    Ibbotson KJ; D'Souza SM; Smith DD; Carpenter G; Mundy GR
    Endocrinology; 1985 Jan; 116(1):469-71. PubMed ID: 2981075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.
    Capparelli C; Kostenuik PJ; Morony S; Starnes C; Weimann B; Van G; Scully S; Qi M; Lacey DL; Dunstan CR
    Cancer Res; 2000 Feb; 60(4):783-7. PubMed ID: 10706080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.
    Thomson BM; Mundy GR; Chambers TJ
    J Immunol; 1987 Feb; 138(3):775-9. PubMed ID: 3805716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.